HALOPERIDOL LACTATE Drug Patent Profile
✉ Email this page to a colleague
When do Haloperidol Lactate patents expire, and what generic alternatives are available?
Haloperidol Lactate is a drug marketed by Actavis Mid Atlantic and is included in one NDA.
The generic ingredient in HALOPERIDOL LACTATE is haloperidol lactate. There are twenty drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the haloperidol lactate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HALOPERIDOL LACTATE?
- What are the global sales for HALOPERIDOL LACTATE?
- What is Average Wholesale Price for HALOPERIDOL LACTATE?
Summary for HALOPERIDOL LACTATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 7 |
| Clinical Trials: | 5 |
| Patent Applications: | 189 |
| DailyMed Link: | HALOPERIDOL LACTATE at DailyMed |
Recent Clinical Trials for HALOPERIDOL LACTATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Christian Hassager | Phase 3 |
| Services Institute of Medical Sciences, Pakistan | Phase 1 |
| University Hospital, Basel, Switzerland | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for HALOPERIDOL LACTATE
US Patents and Regulatory Information for HALOPERIDOL LACTATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Mid Atlantic | HALOPERIDOL LACTATE | haloperidol lactate | SOLUTION;ORAL | 074536-001 | Nov 2, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
